Josh Enomoto

Josh Enomoto

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

3 Reasons Why the Health Crisis Will Be the End for J.C. Penney

Prior to the pandemic, the department store arena was a cruel one for JCP stock. But with Covid-19 wreaking havoc, only a miracle will prevent shares from dropping to zero.

The Coronavirus Makes iBio Finally Relevant

In any other circumstance, IBIO stock is an ultra-risky pharma play. With the coronavirus, it represents an economic lifeline.

Q1 Earnings are Likely to Stall Out any Chance of Ford Stock Acceleration

If you’re looking for a mediocre piece of junk at a great price, Ford cars will do the trick. But you need to stay far away from F stock to avoid devastating your portfolio.

Bad News for BP Is a Once-in-a-Lifetime Deal for Car Buyers

The devastation in the oil markets is only just beginning for BP stock. When you consider the utter lack of demand in the consumer market, the only winners are those lucky enough to be buying cars.

Crude Collapse Isn’t the Only Coronavirus Concern For Chevron

Oil futures briefly dipping below zero obviously bodes poorly for Chevron stock. But there are more factors to keep CVX shares volatile.